Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 122

1.

Meta-transcriptome Profiling of the Human-Leishmania braziliensis Cutaneous Lesion.

Christensen SM, Dillon LA, Carvalho LP, Passos S, Novais FO, Hughitt VK, Beiting DP, Carvalho EM, Scott P, El-Sayed NM, Mosser DM.

PLoS Negl Trop Dis. 2016 Sep 15;10(9):e0004992. doi: 10.1371/journal.pntd.0004992. eCollection 2016 Sep.

2.

Antibody-Guided In Vivo Imaging for Early Detection of Mammary Gland Tumors.

Moore LJ, Roy LD, Zhou R, Grover P, Wu ST, Curry JM, Dillon LM, Puri PM, Yazdanifar M, Puri R, Mukherjee P, Dréau D.

Transl Oncol. 2016 Aug;9(4):295-305. doi: 10.1016/j.tranon.2016.05.001.

3.

Prevalence of Rickettsia species in Dermacentor variabilis ticks from Ontario, Canada.

Wood H, Dillon L, Patel SN, Ralevski F.

Ticks Tick Borne Dis. 2016 Jul;7(5):1044-6. doi: 10.1016/j.ttbdis.2016.06.001. Epub 2016 Jun 4.

PMID:
27318438
4.

The PREX1/Rac signaling axis: Potential as a biomarker and therapeutic target in breast cancer.

Dillon LM, Miller TW.

Mol Cell Oncol. 2015 Apr 30;2(3):e996016. doi: 10.1080/23723556.2014.996016. eCollection 2015 Jul-Sep.

5.

Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures.

Fernandes MC, Dillon LA, Belew AT, Bravo HC, Mosser DM, El-Sayed NM.

MBio. 2016 May 10;7(3). pii: e00027-16. doi: 10.1128/mBio.00027-16.

6.

Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha-Positive, PIK3CA-Mutant Breast Cancer.

Yang W, Hosford SR, Dillon LM, Shee K, Liu SC, Bean JR, Salphati L, Pang J, Zhang X, Nannini MA, Demidenko E, Bates D, Lewis LD, Marotti JD, Eastman AR, Miller TW.

Clin Cancer Res. 2016 May 1;22(9):2250-60. doi: 10.1158/1078-0432.CCR-15-2276. Epub 2016 Jan 5.

PMID:
26733612
7.

Simultaneous transcriptional profiling of Leishmania major and its murine macrophage host cell reveals insights into host-pathogen interactions.

Dillon LA, Suresh R, Okrah K, Corrada Bravo H, Mosser DM, El-Sayed NM.

BMC Genomics. 2015 Dec 29;16(1):1108. doi: 10.1186/s12864-015-2237-2.

8.

STANDARDIZED COMPOUNDING: The Importance of Doing it the Same Way Every Time.

Dillon LR.

Int J Pharm Compd. 2015 Mar-Apr;19(2):109-12.

PMID:
26685491
9.

Neurogenic Bladder and Urodynamic Outcomes in Patients with Spinal Cord Myelopathy.

New PW, Dillon L.

Top Spinal Cord Inj Rehabil. 2015 Summer;21(3):250-6. doi: 10.1309/sci2103-250. Epub 2015 Jul 29.

10.

Controlled whole-body vibration training reduces risk of falls among community-dwelling older adults.

Yang F, King GA, Dillon L, Su X.

J Biomech. 2015 Sep 18;48(12):3206-12. doi: 10.1016/j.jbiomech.2015.06.029. Epub 2015 Jul 6.

PMID:
26189095
11.

Transcriptomic profiling of gene expression and RNA processing during Leishmania major differentiation.

Dillon LA, Okrah K, Hughitt VK, Suresh R, Li Y, Fernandes MC, Belew AT, Corrada Bravo H, Mosser DM, El-Sayed NM.

Nucleic Acids Res. 2015 Aug 18;43(14):6799-813. doi: 10.1093/nar/gkv656. Epub 2015 Jul 6.

12.

Production of Extrachromosomal MicroDNAs Is Linked to Mismatch Repair Pathways and Transcriptional Activity.

Dillon LW, Kumar P, Shibata Y, Wang YH, Willcox S, Griffith JD, Pommier Y, Takeda S, Dutta A.

Cell Rep. 2015 Jun 23;11(11):1749-59. doi: 10.1016/j.celrep.2015.05.020. Epub 2015 Jun 4.

13.

The generation of macrophages with anti-inflammatory activity in the absence of STAT6 signaling.

Fleming BD, Chandrasekaran P, Dillon LA, Dalby E, Suresh R, Sarkar A, El-Sayed NM, Mosser DM.

J Leukoc Biol. 2015 Sep;98(3):395-407. doi: 10.1189/jlb.2A1114-560R. Epub 2015 Jun 5.

14.

Quality control: can compounding pharmacy learn from the automotive industry?

Dillon LR.

Int J Pharm Compd. 2014 Nov-Dec;18(6):475-7.

PMID:
25906624
15.

Sources of marital conflict in five cultures.

Dillon LM, Nowak N, Weisfeld GE, Weisfeld CC, Shattuck KS, Imamoğlu OE, Butovskaya M, Shen J.

Evol Psychol. 2015 Jan 5;13(1):1-15.

PMID:
25560390
16.

The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancer.

Bean JR, Hosford SR, Symonds LK, Owens P, Dillon LM, Yang W, Shee K, Schwartz GN, Marotti JD, Muller KE, Rosenkranz KM, Barth RJ, Chen VS, Agarwal VR, Miller TW.

Breast Cancer Res Treat. 2015 Jan;149(1):69-79. doi: 10.1007/s10549-014-3201-6. Epub 2014 Dec 10.

17.

Estrogen receptor alpha and androgen receptor are commonly expressed in well-differentiated liposarcoma.

Ingram DR, Dillon LM, Lev DC, Lazar A, Demicco EG, Eisenberg BL, Miller TW.

BMC Clin Pathol. 2014 Oct 22;14:42. doi: 10.1186/1472-6890-14-42. eCollection 2014.

18.

P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer.

Dillon LM, Bean JR, Yang W, Shee K, Symonds LK, Balko JM, McDonald WH, Liu S, Gonzalez-Angulo AM, Mills GB, Arteaga CL, Miller TW.

Oncogene. 2015 Jul 23;34(30):3968-76. doi: 10.1038/onc.2014.328. Epub 2014 Oct 6.

19.

Integrating Spanish language training across a Doctor of Physical Therapy curriculum: a case report of one program's evolving model.

Pechak C, Diaz D, Dillon L.

Phys Ther. 2014 Dec;94(12):1807-15. doi: 10.2522/ptj.20130365. Epub 2014 Jul 31.

20.

Diagnostic utility of cerebrospinal fluid flow cytometry in patients with and without prior hematologic malignancy.

Kovach AE, DeLelys ME, Kelliher AS, Dillon LJ, Hasserjian RP, Ferry JA, Preffer FI, Sohani AR.

Am J Hematol. 2014 Oct;89(10):978-84. doi: 10.1002/ajh.23806. Epub 2014 Jul 31.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk